<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1095">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 10, 2022</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00190372</url>
  </required_header>
  <id_info>
    <org_study_id>P030437</org_study_id>
    <nct_id>NCT00190372</nct_id>
  </id_info>
  <brief_title>AIDMA: A Psycho-educational Program Designed to Support and Train Carers of Alzheimer's Disease (AD) Patients</brief_title>
  <official_title>Contribution of a Psycho-Educational Program of Help to Help in the Pharmacological Assumption of Responsibility of the Disease of Alzheimer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - H么pitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - H么pitaux de Paris</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the project is to demonstrate that a psycho-educational programme designed to&#xD;
      support and train carers of Alzheimer's disease (AD) patients induces a significantly higher&#xD;
      benefit than anticholinesterase drug treatment alone or associated to memantine treatment.&#xD;
      This training programme focuses on the explanation/description of behavioral, cognitive and&#xD;
      functional disorders induced by the disease, as well as principles of cognitive and&#xD;
      psycho-social stimulation of the patients in daily life.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Context: Research showing the benefit of a combined approach including specific antidementia&#xD;
      drugs and psycho-educational programmes for caregivers in the caring of Alzheimer's disease&#xD;
      patients is still lacking. We venture the hypothesis that combined treatment including a&#xD;
      specific antidementia drug for the AD patient and a psycho-educational programme for the&#xD;
      caregivers has a larger benefit for both the patient and the caregiver on psychological,&#xD;
      behavioural, and cognitive parameters.&#xD;
&#xD;
      Main objective: to demonstrate that a psycho-educational programme designed to support and&#xD;
      train carers of Alzheimer's disease (AD) patients induces a significantly higher benefit than&#xD;
      anticholinesterase drug treatment alone or associated to memantine treatment.&#xD;
&#xD;
      Secondary objective: identify patterns of responders and non-responders (taking into account&#xD;
      cognitive, psychological parameters).&#xD;
&#xD;
      Methodology: national multicentric, randomized trial, single blinded, with 2 parallel groups&#xD;
      of 120 patients and 120 caregivers trained for a 3 month period with 3 assessments: before,&#xD;
      just after and 3 months after the training period. Patients and caregivers are recruited&#xD;
      (according to exclusion and inclusion criteria) and followed up in memory centers&#xD;
      participating in the trial.&#xD;
&#xD;
      Evaluation criteria:&#xD;
&#xD;
      Primary criteria for the patient: DAD scale (Disability Assessment for Dementia).&#xD;
&#xD;
      Secondary evaluation criteria - for the patient: NPI and ADAS-Cog; for the caregiver: ZARIT&#xD;
      scale, Questionnaire of feeling of competency, Montgomery and Asberg Depression Rating Scale&#xD;
      (MADRS), Geriatric Depression Scale (GDS).&#xD;
&#xD;
      Statistical analysis by the department of biostatistics and medical computing of the Hospital&#xD;
      Cochin will be performed.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2004</start_date>
  <completion_date type="Actual">May 2008</completion_date>
  <primary_completion_date type="Actual">May 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Single (Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>DAD scale (Disability Assessment for Dementia)</measure>
    <time_frame>at 6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>cardiovascular mortality</measure>
    <time_frame>at 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>functional status</measure>
    <time_frame>at 4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>for the patient: NPI and ADAS-Cog</measure>
    <time_frame>during the study</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>for the caregiver: ZARIT scale, questionnaire of feeling of competency, Montgomery and Asberg Depression Rating Scale (MADRS), Geriatric Depression Scale (GDS)</measure>
    <time_frame>during the study</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>all cause mortality</measure>
    <time_frame>at one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>score on a depression rating scale</measure>
    <time_frame>at 6 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">240</enrollment>
  <condition>Alzheimer's Disease</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Controlled diet</intervention_name>
    <description>Controlled diet</description>
    <arm_group_label>A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Self-hypnotic relaxation</intervention_name>
    <description>Self-hypnotic relaxation</description>
    <arm_group_label>A</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Patients:&#xD;
&#xD;
          -  AD outpatients&#xD;
&#xD;
          -  Stable pharmacological treatment&#xD;
&#xD;
          -  Mini-Mental State Examination (MMSE) [10 -28]&#xD;
&#xD;
          -  Age [60-90]&#xD;
&#xD;
          -  Informed consent&#xD;
&#xD;
        Caregivers:&#xD;
&#xD;
          -  Reliability&#xD;
&#xD;
          -  Motivation&#xD;
&#xD;
          -  Psychological disorder related to patient's disease&#xD;
&#xD;
          -  Need for information or help&#xD;
&#xD;
          -  Informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Patients:&#xD;
&#xD;
          -  Other dementia&#xD;
&#xD;
          -  Severe general disease&#xD;
&#xD;
          -  No reliable caregiver&#xD;
&#xD;
        Caregivers:&#xD;
&#xD;
          -  Physical or mental disease incompatible with patient's management&#xD;
&#xD;
          -  Impossibility to participate in the educational program&#xD;
&#xD;
          -  Absence of anxiety-depression&#xD;
&#xD;
          -  Psychotherapy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anne-Sophie Rigaud, Pr, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - H么pitaux de Paris</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Assistance Publique-H么pitaux de Paris</name>
      <address>
        <city>Paris</city>
        <state>Ile de France</state>
        <zip>75010</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Wenisch E, Stoker A, Bourrellis C, Pasquet C, Gauthier E, Corcos E, Banchi MT, De Rotrou J, Rigaud AS. [A global intervention program for institutionalized demented patients]. Rev Neurol (Paris). 2005 Mar;161(3):290-8. French.</citation>
    <PMID>15800450</PMID>
  </reference>
  <verification_date>March 2007</verification_date>
  <study_first_submitted>September 14, 2005</study_first_submitted>
  <study_first_submitted_qc>September 14, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 19, 2005</study_first_posted>
  <last_update_submitted>February 16, 2011</last_update_submitted>
  <last_update_submitted_qc>February 16, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 17, 2011</last_update_posted>
  <responsible_party>
    <name_title>Amel OUSLIMANI</name_title>
    <organization>Department of Clinical Research of developpement</organization>
  </responsible_party>
  <keyword>Alzheimer's disease training programme</keyword>
  <keyword>educational programme caregivers carers dementia treatment</keyword>
  <keyword>Dementia Cognitive disorder</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alzheimer Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypnotics and Sedatives</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

